HCA Healthcare, (Brazil) Performance
| H1CA34 Stock | BRL 96.00 3.95 4.29% |
HCA Healthcare, has a performance score of 1 on a scale of 0 to 100. The firm owns a Beta (Systematic Risk) of -0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning HCA Healthcare, are expected to decrease at a much lower rate. During the bear market, HCA Healthcare, is likely to outperform the market. HCA Healthcare, at this moment owns a risk of 1.76%. Please check out HCA Healthcare, coefficient of variation, variance, and the relationship between the mean deviation and standard deviation , to decide if HCA Healthcare, will be following its current price history.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in HCA Healthcare, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong fundamental indicators, HCA Healthcare, is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 0.98 | |
| Payout Ratio | 8.87% | |
| Fifty Two Week High | 760.28 | |
| Trailing Annual Dividend Yield | 0.08% |
HCA |
HCA Healthcare, Relative Risk vs. Return Landscape
If you would invest 9,513 in HCA Healthcare, on December 14, 2024 and sell it today you would earn a total of 87.00 from holding HCA Healthcare, or generate 0.91% return on investment over 90 days. HCA Healthcare, is generating 0.0311% of daily returns and assumes 1.7641% volatility on return distribution over the 90 days horizon. Simply put, 15% of stocks are less volatile than HCA, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HCA Healthcare, Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HCA Healthcare,'s investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HCA Healthcare,, and traders can use it to determine the average amount a HCA Healthcare,'s price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0176
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | H1CA34 |
Estimated Market Risk
| 1.76 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average HCA Healthcare, is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HCA Healthcare, by adding it to a well-diversified portfolio.
HCA Healthcare, Fundamentals Growth
HCA Stock prices reflect investors' perceptions of the future prospects and financial health of HCA Healthcare,, and HCA Healthcare, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HCA Stock performance.
| Return On Asset | 11.17 | |||
| Profit Margin | 8.99 % | |||
| Operating Margin | 15.09 % | |||
| Current Valuation | 200.48 B | |||
| Shares Outstanding | 622.05 M | |||
| Price To Earning | 8.75 X | |||
| Price To Book | 860.46 X | |||
| Price To Sales | 6.64 X | |||
| Revenue | 59.8 B | |||
| EBITDA | 11.97 B | |||
| Cash And Equivalents | 999 M | |||
| Cash Per Share | 3.45 X | |||
| Total Debt | 39.47 B | |||
| Book Value Per Share | 0.74 X | |||
| Cash Flow From Operations | 8.44 B | |||
| Earnings Per Share | 72.81 X | |||
About HCA Healthcare, Performance
By analyzing HCA Healthcare,'s fundamental ratios, stakeholders can gain valuable insights into HCA Healthcare,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HCA Healthcare, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HCA Healthcare, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee. HCA HEALTHCADRN operates under Medical Care Facilities classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 204000 people.Things to note about HCA Healthcare, performance evaluation
Checking the ongoing alerts about HCA Healthcare, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HCA Healthcare, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating HCA Healthcare,'s performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate HCA Healthcare,'s stock performance include:- Analyzing HCA Healthcare,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HCA Healthcare,'s stock is overvalued or undervalued compared to its peers.
- Examining HCA Healthcare,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HCA Healthcare,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of HCA Healthcare,'s management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HCA Healthcare,'s stock. These opinions can provide insight into HCA Healthcare,'s potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HCA Stock analysis
When running HCA Healthcare,'s price analysis, check to measure HCA Healthcare,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HCA Healthcare, is operating at the current time. Most of HCA Healthcare,'s value examination focuses on studying past and present price action to predict the probability of HCA Healthcare,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HCA Healthcare,'s price. Additionally, you may evaluate how the addition of HCA Healthcare, to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |